Inhibition of advanced protein glycation by 8-quinolinecarboxylic hydrazide

Pharmacology

Volumn 52, Issue 5, 1996, Pages 314-320

  Miwa, Ichitomo ^a   Tsugawa, Tohru ^a   Koyasu, Katsuya ^b   Terada, Yukimasa ^b  

^a Department of Pathobiochemistry ^*  (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

8 Quinolinecarboxylic hydrazide; Advanced protein glycation; Aminoguanidine; Hydrazide compounds

Indexed keywords

4 NITROBENZOIC HYDRAZIDE; AMINOGUANIDINE; BOVINE SERUM ALBUMIN; HYDRAZIDE; ISONIAZID; MANNOSE; P ANISIC HYDRAZIDE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

EID: 0029974764     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139396     Document Type: Article

References (20)

1. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N Engl J Med 1988;318:1315-1321.
2. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A: Aminoguanid-inc prevents diabetes-induced arterial wall protein cross-linking, Science 1986;232:1629-1632.
3. Huby R, Harding JJ: Non-enzymic glycosylation (glycation) oflens proteins by galactose and protection by aspirin and reduced glutathione, Exp Eye Res 1988:47:53-59.
4. Bruno MR, Sensi M, Cioccia GP, Valente L, Negri M, Ghirlanda G, Pozzilli P: Inhibition of protein non-enzymic glycation induced by ben-dazac, Diabetes Res 1988:9:11-14.
5. Sensi M, Pricci F, Dc Rossi MG, Morano S, Di Mario U: D-Lysine effectively decreases the non-enzymic glycation of proteins in vitro, Clin Chem 1989:35:384-387.
6. Raza K, Harding JJ: Non-enzymic modification oflens proteins by glucose and fructose: Effects of ibuprof-en, Exp Eye Res 1991:52:205-212.
7. Ceriello A, Giugliano D, Qualraro A, Donzella C, Dipalo G, Lefebvre PJ: Vitamin E reduction of protein glycosylation in diabetes: New prospect for prevention of diabetic complications? Diabetes Care 1991; 14: 68-72.
8. Menzcll EJ, Rcihsner R: Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine, Diabeto-logia 1991;34:12-16.
9. Lc Gucn CA, Bain S, Barnett AH, Luncc J: Captopril inhibits the fluorescence development associated with glycation of proteins, Agents Actions 1992;36:264-270.
10. van Boekel MAM, van den Bergh PJPC, Hocnders HJ: Glycation of human serum albumin: Inhibition by Diclofenac, Biochim Biophys Acta 1992;1120:201-204.
11. Kawabata T, Packer L: u-Lipoate can protect against glycation of serum albumin, but not low density lipoprotein, Biochem Biophys Res Commun 1994;203:99-104.
12. Khatami M, Suldan Z, David I, Li W, Rockcy JH: Inhibitory etfects of pyridoxal phosphate, ascorbate and aminoguanidine on noncnzymatic glycosylation, Life Sci 1988:43: 1725-1731.
13. Hammcs H-P, Martin S, Fedcrlin K, Geisen K, Brownlee M: Aminoguan-idinc treatment inhibits the development of experimental diabetic retinopathy, Proc Natl Acad Sci USA 1991;88:11555-11558.
14. Soulis-liparota T, Cooper M, Papa-zoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat, Diabetes 1991:40:1328-1334.
15. Cameron NE, Cotter MA, Dines K, Love A: Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in strep-tozotocin-diabetic rats, Diabetolog-ia 1992;35:946-950.
16. Yagihashi S, Karnijo M, Baba M, Yagihashi N, Nagai K: Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats, Diabetes 1992;41:47-52.
17. Ahmed N, Furth AJ: A microassay for protein glycation based on the periodate method, Anal Biochem 1991;192:109-111.
18. Stewart JPP: MOPAC: A semiem-pirical molecular orbital program, J Comput Aided Mol Des 1990,4:1-103.
19. Hayward LD, Angyal SJ: A symmetry rule for the circular dichroism of reducing sugars, and the proportion of carbonyl forms in aqueous solutions thereof, Carbohydr Res 1977; 53:13-20.
20. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine, Diabetes 1992:41:26-29.